Welcome to MedsFacts the next generation reference for medication safety. With more than 70% of all Americans currently taking at least one prescription drug – and at least 50% of all Americans taking two or more medications – it’s more critical than ever that we are informed, engaged and aware of potential side effects and adverse reactions.

MedsFacts is the premiere destination for the latest prescription drug and healthcare news. MedsFacts analyzes more than 18 million FDA adverse drug reports for 20,000 different pharmaceutical products, enabling patients and providers to better understand the potential side effects of different medications, along with potentially harmful interactions. Our easy-to-use online tools help you quickly assess the benefits and potential dangers associated with different medications. These easy-to-use diagnostic tools empower you to take charge of your health!

In conjunction with our redesigned website launch, the MedsFacts team is excited to announce our newest feature: the ability to consult with expert physicians and scientific researchers about different prescription medications. Patients can ask questions about their medications, providers can post responses to patient concerns, and patients can also schedule a personal consultation with a medication expert – all from within the MedsFacts website.

Using our community forum, you can share your own experience with different medications. Did you find that the side effects for a specific drug did not seem to apply to you? Or maybe you experienced other difficulties while taking a specific medication. Share your experiences and interact with other patients who are also taking similar medications for similar health concerns.

As a registered MedsFacts user, you can privately and securely save your medication list to the cloud. Once you’ve saved your medication list, you can receive regular updates from other patients posting questions or concerns about the same medications on your watch list. You control your communication preferences so you only receive the updates that are most relevant to your health concerns.

Wondering whether it is safe to take two medications together? Confused about your medical provider’s prescriptions? Curious if others are experiencing the same side effects as you? Sign up for MedsFacts today. Joining MedsFacts is completely free and will give you access to all our easy-to-use tools, including expert physician and researcher consultations and our community forums. You’ll be able to view user comments and concerns, and interact with patients who take similar medications.

Stay informed and take control of your health: click here to join the growing MedsFacts community.

 

About this MedsFacts analysis covering adverse side effect reports of ATENOLOL patients who developed OXYGEN SATURATION DECREASED.

MedsFacts provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and MedsFacts user submissions. Between January 2004 and October 2012, 220 individuals taking ATENOLOL reported OXYGEN SATURATION DECREASED to the FDA. A total of 59469 ATENOLOL drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ATENOLOL and OXYGEN SATURATION DECREASED. In doing so, we compare ATENOLOL with other drugs that cause OXYGEN SATURATION DECREASED, to help you evaluate whether or not ATENOLOL causes OXYGEN SATURATION DECREASED. Likewise, this page shows the most highly-reported side effects of ATENOLOL, so you can see if OXYGEN SATURATION DECREASED ranks among ATENOLOL's most well-known side effects.
Summary Statistics
Reports of ATENOLOL causing OXYGEN SATURATION DECREASED: 220
Reports of any side effect of ATENOLOL : 59469
Percentage of ATENOLOL patients where OXYGEN SATURATION DECREASED is a reported side effect: 0.3699%

FDA reports of any drug causing OXYGEN SATURATION DECREASED : 11423
Average percentage for all medicated patients where OXYGEN SATURATION DECREASED is reported as a complication: 0.0716%

Physician opinion on ATENOLOL as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ATENOLOL:
HYPERTENSION ( 9133 patients )
DRUG USE FOR UNKNOWN INDICATION ( 2531 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 2247 patients )
BLOOD PRESSURE ( 918 patients )
CARDIAC DISORDER ( 464 patients )
ATRIAL FIBRILLATION ( 324 patients )
BLOOD PRESSURE INCREASED ( 285 patients )
BLOOD PRESSURE ABNORMAL ( 211 patients )
ARRHYTHMIA ( 203 patients )
TACHYCARDIA ( 186 patients )
ANGINA PECTORIS ( 181 patients )
PALPITATIONS ( 161 patients )
HEART RATE IRREGULAR ( 156 patients )
MYOCARDIAL ISCHAEMIA ( 131 patients )
CORONARY ARTERY DISEASE ( 126 patients )
ILL-DEFINED DISORDER ( 117 patients )
ESSENTIAL HYPERTENSION ( 113 patients )
HEART RATE INCREASED ( 107 patients )
MYOCARDIAL INFARCTION ( 95 patients )
MIGRAINE ( 57 patients )
MITRAL VALVE PROLAPSE ( 50 patients )
SUPRAVENTRICULAR TACHYCARDIA ( 49 patients )
PROPHYLAXIS ( 48 patients )
HEART RATE ( 40 patients )
CARDIAC FAILURE CONGESTIVE ( 35 patients )
HEART RATE ABNORMAL ( 28 patients )
CARDIOMYOPATHY ( 27 patients )
HEADACHE ( 26 patients )
BLOOD PRESSURE MANAGEMENT ( 24 patients )
VENTRICULAR EXTRASYSTOLES ( 23 patients )
MIGRAINE PROPHYLAXIS ( 22 patients )
SINUS TACHYCARDIA ( 22 patients )
CARDIOVASCULAR EVENT PROPHYLAXIS ( 21 patients )
CARDIOVASCULAR DISORDER ( 21 patients )
HYPOTENSION ( 19 patients )
ATRIAL TACHYCARDIA ( 15 patients )
ATRIAL FLUTTER ( 15 patients )
HYPERTONIA ( 15 patients )
SUICIDE ATTEMPT ( 15 patients )
ANXIETY ( 14 patients )
OVERDOSE ( 14 patients )
CARDIAC FAILURE ( 13 patients )
TREMOR ( 13 patients )
PERICARDITIS ( 12 patients )
ISCHAEMIC CARDIOMYOPATHY ( 11 patients )
HEART RATE DECREASED ( 11 patients )
SUPRAVENTRICULAR EXTRASYSTOLES ( 11 patients )
PAIN ( 10 patients )
HYPERTHYROIDISM ( 10 patients )
GLAUCOMA ( 9 patients )
TACHYARRHYTHMIA ( 9 patients )
ACUTE MYOCARDIAL INFARCTION ( 9 patients )
BLOOD CHOLESTEROL INCREASED ( 9 patients )
CHEST PAIN ( 9 patients )
WOLFF-PARKINSON-WHITE SYNDROME ( 8 patients )
BLOOD CHOLESTEROL ABNORMAL ( 8 patients )
DIURETIC THERAPY ( 8 patients )
CORONARY ARTERIAL STENT INSERTION ( 7 patients )
CEREBROVASCULAR ACCIDENT PROPHYLAXIS ( 7 patients )
SECONDARY HYPERTENSION ( 7 patients )
COMPLETED SUICIDE ( 7 patients )
INCORRECT DOSE ADMINISTERED ( 7 patients )
VENTRICULAR TACHYCARDIA ( 7 patients )
DRUG THERAPY ( 6 patients )
BRADYCARDIA ( 6 patients )
DIABETES MELLITUS ( 6 patients )
PREMEDICATION ( 6 patients )
RENAL DISORDER ( 6 patients )
AORTIC VALVE REPLACEMENT ( 6 patients )
MITRAL VALVE DISEASE ( 6 patients )
ARTERIOSCLEROSIS ( 6 patients )
LABILE HYPERTENSION ( 5 patients )
TYPE 2 DIABETES MELLITUS ( 5 patients )
CARDIAC OPERATION ( 5 patients )
STENT PLACEMENT ( 5 patients )
RENAL TRANSPLANT ( 5 patients )
ARRHYTHMIA SUPRAVENTRICULAR ( 5 patients )
ARTERIAL OCCLUSIVE DISEASE ( 5 patients )
MALIGNANT HYPERTENSION ( 5 patients )
BLOOD PRESSURE DECREASED ( 5 patients )
CARDIAC MURMUR ( 5 patients )
HYPERCHOLESTEROLAEMIA ( 4 patients )
SYNCOPE ( 4 patients )
RHEUMATOID ARTHRITIS ( 4 patients )
BLOOD CHOLESTEROL ( 4 patients )
HYPERTENSIVE CARDIOMYOPATHY ( 4 patients )
CORONARY ARTERY INSUFFICIENCY ( 4 patients )
HYPERTROPHIC CARDIOMYOPATHY ( 4 patients )
CARDIAC FLUTTER ( 4 patients )
BLOOD PRESSURE FLUCTUATION ( 4 patients )
UNEVALUABLE EVENT ( 4 patients )
DRUG EXPOSURE DURING PREGNANCY ( 4 patients )
FOETAL EXPOSURE DURING PREGNANCY ( 4 patients )
INTENTIONAL OVERDOSE ( 4 patients )
ISCHAEMIC HEART DISEASE PROPHYLAXIS ( 4 patients )
SYSTEMIC LUPUS ERYTHEMATOSUS ( 4 patients )
ACUTE CORONARY SYNDROME ( 4 patients )
CEREBROVASCULAR ACCIDENT ( 4 patients )
HYPERTENSIVE HEART DISEASE ( 4 patients )
TRANSIENT ISCHAEMIC ATTACK ( 4 patients )
SENSATION OF PRESSURE ( 4 patients )
AORTIC DILATATION ( 4 patients )
PULSE ABNORMAL ( 3 patients )
INFARCTION ( 3 patients )
MIGRAINE WITH AURA ( 3 patients )
CROHN'S DISEASE ( 3 patients )
LONG QT SYNDROME CONGENITAL ( 3 patients )
ANGINA UNSTABLE ( 3 patients )
MARFAN'S SYNDROME ( 3 patients )
VASCULAR GRAFT ( 3 patients )
ESSENTIAL TREMOR ( 3 patients )
DEPRESSION ( 3 patients )
CHEST DISCOMFORT ( 3 patients )
DRESSLER'S SYNDROME ( 3 patients )
HEPATIC CIRRHOSIS ( 2 patients )
AORTIC VALVE DISEASE ( 2 patients )
GASTROOESOPHAGEAL REFLUX DISEASE ( 2 patients )
AORTIC VALVE STENOSIS ( 2 patients )
OSTEOPENIA ( 2 patients )
BASEDOW'S DISEASE ( 2 patients )
ARRHYTHMIA PROPHYLAXIS ( 2 patients )
CEREBRAL DISORDER ( 2 patients )
ARTERIAL DISORDER ( 2 patients )
LIPIDS INCREASED ( 2 patients )
PANIC ATTACK ( 2 patients )
TRANSPLANT REJECTION ( 2 patients )
ARTERIOSCLEROSIS CORONARY ARTERY ( 2 patients )
MENOPAUSAL SYMPTOMS ( 2 patients )
AORTIC ANEURYSM ( 2 patients )
CARDIAC PACEMAKER INSERTION ( 2 patients )
PULMONARY ARTERIAL HYPERTENSION ( 2 patients )
OEDEMA ( 2 patients )
CARDIOMEGALY ( 2 patients )
BLOOD TRIGLYCERIDES INCREASED ( 2 patients )
CONVULSION ( 2 patients )
GENERAL PHYSICAL HEALTH DETERIORATION ( 2 patients )
HYPERHIDROSIS ( 2 patients )
CORONARY ARTERY BYPASS ( 2 patients )
AGE INDETERMINATE MYOCARDIAL INFARCTION ( 2 patients )
ELECTROCARDIOGRAM QT PROLONGED ( 2 patients )
SALIVARY HYPERSECRETION ( 2 patients )
CARDIAC FAILURE CHRONIC ( 2 patients )
POISONING DELIBERATE ( 2 patients )
ANTICOAGULANT THERAPY ( 2 patients )
EXTRASYSTOLES ( 2 patients )
CARDIAC VALVE DISEASE ( 1 patients )
VASODILATION PROCEDURE ( 1 patients )
BLOOD TRIGLYCERIDES ( 1 patients )
CONGENITAL PULMONARY VALVE ATRESIA ( 1 patients )
ORGAN FAILURE ( 1 patients )
ABDOMINAL PAIN ( 1 patients )
ATTENTION DEFICIT/HYPERACTIVITY DISORDER ( 1 patients )
DRUG WITHDRAWAL SYNDROME ( 1 patients )
RENAL HYPERTENSION ( 1 patients )
VENTRICULAR HYPERTROPHY ( 1 patients )
ACCIDENTAL OVERDOSE ( 1 patients )
DYSTONIA ( 1 patients )
HYPERLIPIDAEMIA ( 1 patients )
MITRAL VALVE INCOMPETENCE ( 1 patients )
WHEEZING ( 1 patients )
BUNDLE BRANCH BLOCK RIGHT ( 1 patients )
ELECTROCARDIOGRAM QT INTERVAL ( 1 patients )
MOOD SWINGS ( 1 patients )
ROUTINE HEALTH MAINTENANCE ( 1 patients )
THYROID DISORDER ( 1 patients )
ANEURYSM ( 1 patients )
MULTIPLE SCLEROSIS ( 1 patients )
ARTERIAL STENT INSERTION ( 1 patients )
PERIPHERAL VASCULAR DISORDER ( 1 patients )
CHANGE OF BOWEL HABIT ( 1 patients )
EXTRAPYRAMIDAL DISORDER ( 1 patients )
SICK SINUS SYNDROME ( 1 patients )
EYE DISORDER ( 1 patients )
HYPOTHYROIDISM ( 1 patients )
NERVOUSNESS ( 1 patients )
SLEEP DISORDER ( 1 patients )
ATHEROSCLEROSIS ( 1 patients )
DIZZINESS ( 1 patients )
HEART TRANSPLANT ( 1 patients )
FIBROMYALGIA ( 1 patients )
IMMUNOSUPPRESSION ( 1 patients )
NEUROPATHY PERIPHERAL ( 1 patients )
HEART VALVE REPLACEMENT ( 1 patients )
MICROVASCULAR ANGINA ( 1 patients )
AORTIC VALVE CALCIFICATION ( 1 patients )
BLOOD PRESSURE SYSTOLIC INCREASED ( 1 patients )
COMPUTERISED TOMOGRAM CORONARY ARTERY ( 1 patients )
ABDOMINAL DISCOMFORT ( 1 patients )
ATRIOVENTRICULAR BLOCK ( 1 patients )
HYPERADRENALISM ( 1 patients )
ORTHOSTATIC HYPOTENSION ( 1 patients )
SURGERY ( 1 patients )
ACCIDENTAL EXPOSURE ( 1 patients )
AUTONOMIC NERVOUS SYSTEM IMBALANCE ( 1 patients )
DYSPNOEA ( 1 patients )
BUNDLE BRANCH BLOCK LEFT ( 1 patients )
HAEMORRHAGE ( 1 patients )
BIPOLAR DISORDER ( 1 patients )
CEREBRAL ATHEROSCLEROSIS ( 1 patients )
EHLERS-DANLOS SYNDROME ( 1 patients )
ROSACEA ( 1 patients )
CORONARY ARTERY DISSECTION ( 1 patients )
HEART DISEASE CONGENITAL ( 1 patients )
LEFT VENTRICULAR HYPERTROPHY ( 1 patients )
MULTIPLE DRUG OVERDOSE INTENTIONAL ( 1 patients )
CORONARY REVASCULARISATION ( 1 patients )
LIVER DISORDER ( 1 patients )
CEREBROVASCULAR ARTERIOVENOUS MALFORMATION ( 1 patients )
MUSCLE SPASMS ( 1 patients )
CARDIAC FIBRILLATION ( 1 patients )
Drugs with high FDA adverse event association with OXYGEN SATURATION DECREASED:

ASPIRIN (899 patients)
REMICADE (797 patients)
LASIX (594 patients)
FUROSEMIDE (404 patients)
PREDNISONE (400 patients)
ACETAMINOPHEN (385 patients)
ALBUTEROL (346 patients)
PREDNISOLONE (327 patients)
OMEPRAZOLE (327 patients)
METHOTREXATE (320 patients)
FENTANYL (320 patients)
MORPHINE (306 patients)
SYNAGIS (299 patients)
PROPOFOL (296 patients)
NEXIUM (296 patients)
LISINOPRIL (291 patients)
TRACLEER (288 patients)
COUMADIN (286 patients)
FORTEO (281 patients)
FOLIC ACID (278 patients)
OXYGEN (275 patients)
SPIRIVA (274 patients)
BENADRYL (271 patients)
POTASSIUM CHLORIDE (260 patients)
DIGOXIN (256 patients)
LIPITOR (253 patients)
SYNTHROID (250 patients)
LETAIRIS (242 patients)
PAXIL (240 patients)
HUMIRA (237 patients)
ADVAIR DISKUS 100/50 (229 patients)
CLOZARIL (227 patients)
DEXAMETHASONE (225 patients)
SOLU-MEDROL (224 patients)
ATENOLOL (220 patients)
PLAVIX (220 patients)
ALLOPURINOL (219 patients)
LORAZEPAM (217 patients)
SIMVASTATIN (215 patients)
PROTONIX (208 patients)
CYCLOPHOSPHAMIDE (207 patients)
ZOFRAN (204 patients)
NORVASC (201 patients)
OXYCONTIN (200 patients)
ATIVAN (196 patients)
HEPARIN SODIUM INJECTION (196 patients)
MORPHINE SULFATE (196 patients)
XANAX (195 patients)
VIOXX (195 patients)
LEVOTHYROXINE SODIUM (194 patients)
CARBOPLATIN (190 patients)
FOSAMAX (190 patients)
NEURONTIN (188 patients)
HYDROCHLOROTHIAZIDE (184 patients)
AVONEX (180 patients)
HEPARIN (179 patients)
GLEEVEC (178 patients)
WARFARIN SODIUM (177 patients)
ZOLOFT (176 patients)
DECADRON (172 patients)
PREDNISONE TAB (169 patients)
LEVAQUIN (163 patients)
LYRICA (163 patients)
VITAMIN D (162 patients)
LANSOPRAZOLE (162 patients)
PREVACID (158 patients)
CLONAZEPAM (155 patients)
ZANTAC (152 patients)
DILAUDID (150 patients)
OXYCODONE HCL (147 patients)
GABAPENTIN (144 patients)
EXJADE (143 patients)
HYDROCORTISONE (143 patients)
VANCOMYCIN (142 patients)
SINGULAIR (141 patients)
DIAZEPAM (141 patients)
INSULIN (140 patients)
IBUPROFEN (140 patients)
METFORMIN HCL (140 patients)
METOPROLOL TARTRATE (140 patients)
MIDAZOLAM HCL (140 patients)
DIOVAN (138 patients)
AMBIEN (137 patients)
LEXAPRO (137 patients)
SEROQUEL (137 patients)
TYLENOL (134 patients)
RANITIDINE (134 patients)
FAMOTIDINE (132 patients)
THYMOGLOBULIN (128 patients)
ALDACTONE (128 patients)
PRILOSEC (128 patients)
VICODIN (128 patients)
MYCOPHENOLATE MOFETIL (128 patients)
CYCLOSPORINE (126 patients)
CALCIUM (124 patients)
ELOXATIN (124 patients)
FLUOROURACIL (124 patients)
AMLODIPINE (123 patients)
ONDANSETRON (122 patients)
REVATIO (122 patients)
TAXOTERE (122 patients)
SPIRONOLACTONE (121 patients)
ERBITUX (121 patients)
ZOMETA (119 patients)
PACLITAXEL (119 patients)
XOLAIR (118 patients)
TOPROL-XL (117 patients)
CYTARABINE (117 patients)
ATARAX (117 patients)
ALPRAZOLAM (117 patients)
FENTANYL CITRATE (116 patients)
ZITHROMAX (116 patients)
BACTRIM (116 patients)
TYLENOL (CAPLET) (116 patients)
MULTI-VITAMIN (115 patients)
CISPLATIN (114 patients)
ZOCOR (111 patients)
REGLAN (111 patients)
METHYLPREDNISOLONE (110 patients)
TAXOL (108 patients)
NITROGLYCERIN (107 patients)
ACYCLOVIR (107 patients)
FLUCONAZOLE (105 patients)
SYMBICORT (104 patients)
HEPARIN SODIUM (104 patients)
MYOZYME (103 patients)
PERCOCET (103 patients)
LOVENOX (102 patients)
TACROLIMUS (101 patients)
TRAMADOL HCL (101 patients)
MULTI-VITAMINS (100 patients)
VELCADE (100 patients)
GAMMAGARD LIQUID (98 patients)
VITAMIN TAB (98 patients)
METOCLOPRAMIDE (98 patients)
FLUOXETINE (98 patients)
COREG (96 patients)
ATROVENT (95 patients)
DURAGESIC-100 (95 patients)
SEVOFLURANE (94 patients)
LORTAB (94 patients)
PANTOPRAZOLE (94 patients)
COMBIVENT (94 patients)
PROZAC (93 patients)
COLACE (93 patients)
RISPERDAL (93 patients)
LANTUS (92 patients)
ENALAPRIL MALEATE (92 patients)
LACTULOSE (91 patients)
ZYRTEC (90 patients)
VOLTAREN (90 patients)
VENTOLIN (90 patients)
SOLU-CORTEF (89 patients)
NYSTATIN (89 patients)
XOPENEX (88 patients)
LIDOCAINE (88 patients)
CLOZAPINE (88 patients)
ENBREL (88 patients)
VALIUM (87 patients)
METOPROLOL (87 patients)
AVASTIN (87 patients)
CALCIUM CARBONATE (86 patients)
TEGRETOL (86 patients)
SANDIMMUNE (85 patients)
AMOXICILLIN (85 patients)
CYMBALTA (85 patients)
TYSABRI (84 patients)
EPINEPHRINE (83 patients)
LEUCOVORIN CALCIUM (83 patients)
CLONIDINE (82 patients)
TEMAZEPAM (82 patients)
ZYPREXA (82 patients)
CODEINE PHOSPHATE (82 patients)
AUGMENTIN '125' (82 patients)
AVELOX (81 patients)
BACLOFEN (81 patients)
PROMETHAZINE (81 patients)
LAMOTRIGINE (81 patients)
TOCILIZUMAB (81 patients)
OXALIPLATIN (80 patients)
CITALOPRAM HYDROBROMIDE (80 patients)
ACTEMRA (80 patients)
HYDROMORPHONE HCL (80 patients)
ETOPOSIDE (80 patients)
CELEBREX (80 patients)
OLANZAPINE (80 patients)
INOMAX (79 patients)
PROGRAF (78 patients)
LEVOFLOXACIN (78 patients)
KLONOPIN (77 patients)
CRESTOR (77 patients)
DESFERAL (77 patients)
PREDONINE (76 patients)
ASCORBIC ACID (76 patients)
MAGNESIUM OXIDE (76 patients)
CLARITHROMYCIN (76 patients)
DIPRIVAN (76 patients)
CELECOXIB (75 patients)
CELEXA (75 patients)
VALPROATE SODIUM (75 patients)
DIPHENHYDRAMINE HCL (74 patients)
PRAVASTATIN (74 patients)
DEMEROL (74 patients)
FERROUS SULFATE TAB (74 patients)
FLEXERIL (74 patients)
EFFEXOR (74 patients)
DEPAKOTE (73 patients)
GLIPIZIDE (73 patients)
METOPROLOL SUCCINATE (73 patients)
GLUCOPHAGE (73 patients)
Most common side effects for patients taking ATENOLOL:
NAUSEA (4086 patients)
DIZZINESS (3642 patients)
PAIN (3587 patients)
DYSPNOEA (3545 patients)
FATIGUE (3076 patients)
DIARRHOEA (3014 patients)
ASTHENIA (2931 patients)
DRUG INEFFECTIVE (2820 patients)
ANXIETY (2728 patients)
HEADACHE (2625 patients)
FALL (2605 patients)
VOMITING (2571 patients)
HYPERTENSION (2550 patients)
CHEST PAIN (2421 patients)
OEDEMA PERIPHERAL (2305 patients)
MYOCARDIAL INFARCTION (2220 patients)
HYPOTENSION (2155 patients)
ARTHRALGIA (2146 patients)
PAIN IN EXTREMITY (2042 patients)
DEPRESSION (1992 patients)
WEIGHT DECREASED (1893 patients)
BACK PAIN (1866 patients)
ANAEMIA (1842 patients)
RENAL FAILURE ACUTE (1800 patients)
MALAISE (1772 patients)
CEREBROVASCULAR ACCIDENT (1703 patients)
PYREXIA (1688 patients)
INSOMNIA (1653 patients)
ATRIAL FIBRILLATION (1643 patients)
MYALGIA (1626 patients)
RENAL FAILURE (1624 patients)
BLOOD PRESSURE INCREASED (1579 patients)
DEHYDRATION (1559 patients)
ABDOMINAL PAIN (1536 patients)
PNEUMONIA (1521 patients)
DRUG INTERACTION (1495 patients)
CONFUSIONAL STATE (1493 patients)
BLOOD GLUCOSE INCREASED (1437 patients)
INJURY (1408 patients)
CARDIAC FAILURE CONGESTIVE (1408 patients)
PRURITUS (1388 patients)
RASH (1352 patients)
SYNCOPE (1317 patients)
COUGH (1276 patients)
WEIGHT INCREASED (1274 patients)
CONSTIPATION (1259 patients)
URINARY TRACT INFECTION (1240 patients)
FEELING ABNORMAL (1228 patients)
PARAESTHESIA (1174 patients)
MUSCLE SPASMS (1173 patients)
BRADYCARDIA (1166 patients)
PALPITATIONS (1153 patients)
HYPOAESTHESIA (1137 patients)
DIABETES MELLITUS (1124 patients)
CORONARY ARTERY DISEASE (1118 patients)
SOMNOLENCE (1106 patients)
DEATH (1089 patients)
HYPERHIDROSIS (1082 patients)
ABDOMINAL PAIN UPPER (1076 patients)
GAIT DISTURBANCE (1074 patients)
DECREASED APPETITE (1042 patients)
LOSS OF CONSCIOUSNESS (1038 patients)
TREMOR (1026 patients)
FLUSHING (1024 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (994 patients)
MUSCULAR WEAKNESS (993 patients)
CONDITION AGGRAVATED (981 patients)
BLOOD CREATININE INCREASED (922 patients)
EMOTIONAL DISTRESS (912 patients)
HAEMOGLOBIN DECREASED (899 patients)
VISION BLURRED (897 patients)
CONVULSION (865 patients)
OSTEOARTHRITIS (848 patients)
PULMONARY EMBOLISM (846 patients)
ERYTHEMA (810 patients)
DYSPEPSIA (787 patients)
CARDIAC DISORDER (778 patients)
BLOOD CHOLESTEROL INCREASED (777 patients)
CHEST DISCOMFORT (768 patients)
CARDIAC ARREST (764 patients)
THROMBOCYTOPENIA (717 patients)
RENAL IMPAIRMENT (709 patients)
HEART RATE INCREASED (707 patients)
DYSPHAGIA (705 patients)
PLEURAL EFFUSION (702 patients)
CHILLS (702 patients)
DEEP VEIN THROMBOSIS (695 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (694 patients)
ANGINA PECTORIS (682 patients)
ANHEDONIA (676 patients)
RHABDOMYOLYSIS (675 patients)
INFECTION (669 patients)
OSTEONECROSIS OF JAW (664 patients)
SEPSIS (659 patients)
NEUROPATHY PERIPHERAL (656 patients)
ACUTE MYOCARDIAL INFARCTION (634 patients)
TACHYCARDIA (633 patients)
RESPIRATORY FAILURE (628 patients)
GASTROINTESTINAL HAEMORRHAGE (628 patients)
BLOOD PRESSURE DECREASED (625 patients)
HYPOKALAEMIA (623 patients)
LETHARGY (613 patients)
HYPERSENSITIVITY (611 patients)
UNEVALUABLE EVENT (611 patients)
AMNESIA (603 patients)
OEDEMA (600 patients)
ALANINE AMINOTRANSFERASE INCREASED (598 patients)
OVERDOSE (595 patients)
PLATELET COUNT DECREASED (594 patients)
JOINT SWELLING (590 patients)
ABDOMINAL DISTENSION (588 patients)
DRY MOUTH (588 patients)
COMPLETED SUICIDE (583 patients)
TRANSIENT ISCHAEMIC ATTACK (579 patients)
CONTUSION (577 patients)
HYPONATRAEMIA (576 patients)
BRONCHITIS (572 patients)
ARTHRITIS (571 patients)
HYPERKALAEMIA (563 patients)
BALANCE DISORDER (559 patients)
CELLULITIS (556 patients)
ARRHYTHMIA (555 patients)
INTERNATIONAL NORMALISED RATIO INCREASED (547 patients)
SINUSITIS (545 patients)
URTICARIA (545 patients)
MEMORY IMPAIRMENT (544 patients)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (543 patients)
SWELLING (542 patients)
OSTEOMYELITIS (540 patients)
MULTI-ORGAN FAILURE (537 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (537 patients)
HAEMORRHAGE (536 patients)
PANCREATITIS (534 patients)
FEAR (530 patients)
CARDIOMEGALY (523 patients)
BONE DISORDER (522 patients)
MUSCULOSKELETAL PAIN (522 patients)
PULMONARY OEDEMA (517 patients)
STRESS (514 patients)
BLOOD UREA INCREASED (513 patients)
ALOPECIA (508 patients)
CATARACT (507 patients)
NECK PAIN (507 patients)
RECTAL HAEMORRHAGE (506 patients)
PHARMACEUTICAL PRODUCT COMPLAINT (500 patients)
HYPERLIPIDAEMIA (497 patients)
ABDOMINAL DISCOMFORT (496 patients)
HYPERGLYCAEMIA (484 patients)
FEELING HOT (480 patients)
HYPOGLYCAEMIA (480 patients)
BONE PAIN (476 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (471 patients)
BURNING SENSATION (468 patients)
OSTEONECROSIS (468 patients)
RENAL FAILURE CHRONIC (456 patients)
IMPAIRED HEALING (455 patients)
MUSCULOSKELETAL STIFFNESS (451 patients)
EPISTAXIS (450 patients)
SWELLING FACE (447 patients)
NERVOUSNESS (444 patients)
PANCYTOPENIA (441 patients)
MYOCARDIAL ISCHAEMIA (440 patients)
DYSGEUSIA (440 patients)
CHOLELITHIASIS (438 patients)
HALLUCINATION (437 patients)
NEUTROPENIA (436 patients)
ANOREXIA (432 patients)
OSTEOPOROSIS (430 patients)
AGITATION (429 patients)
INJECTION SITE PAIN (424 patients)
PAIN IN JAW (424 patients)
THROMBOSIS (422 patients)
HAEMATOCRIT DECREASED (418 patients)
TYPE 2 DIABETES MELLITUS (418 patients)
VERTIGO (418 patients)
GASTRITIS (411 patients)
WHITE BLOOD CELL COUNT DECREASED (407 patients)
CARDIO-RESPIRATORY ARREST (406 patients)
SPEECH DISORDER (404 patients)
INFLUENZA LIKE ILLNESS (403 patients)
INCORRECT DOSE ADMINISTERED (401 patients)
DRUG HYPERSENSITIVITY (397 patients)
HEART RATE DECREASED (395 patients)
HAEMORRHOIDS (394 patients)
CORONARY ARTERY OCCLUSION (393 patients)
FLATULENCE (390 patients)
MITRAL VALVE INCOMPETENCE (390 patients)
DIVERTICULUM (389 patients)
ATELECTASIS (388 patients)
BLOOD GLUCOSE DECREASED (384 patients)
SPINAL OSTEOARTHRITIS (384 patients)
HAEMATURIA (382 patients)
SUICIDAL IDEATION (382 patients)
HOT FLUSH (379 patients)
URINARY INCONTINENCE (379 patients)
TOOTH EXTRACTION (378 patients)
MENTAL STATUS CHANGES (378 patients)
NASOPHARYNGITIS (378 patients)
ABASIA (376 patients)
NEPHROLITHIASIS (372 patients)
DYSARTHRIA (370 patients)
HEART RATE IRREGULAR (369 patients)
DRUG TOXICITY (368 patients)
CARDIAC FAILURE (368 patients)
WHITE BLOOD CELL COUNT INCREASED (368 patients)
INTERVERTEBRAL DISC PROTRUSION (367 patients)
SINUS BRADYCARDIA (363 patients)
ARTHROPATHY (363 patients)
RENAL INJURY (360 patients)
ASTHMA (358 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the MedsFacts community - currently one million members and growing! MedsFacts online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent MedsFacts Activity for ATENOLOL


Issue Description / Topic Timestamp
QUESTION
B-CELL SMALL LYMPHOCYTIC LYMPHOMA
I believe that Atenalol is a big risk factor for clonosonal b cell lymohocytosis 2014-11-15 15:59:18
QUESTION
WHITE BLOOD CELL COUNT INCREASED
Atenalol causes hair loss 2014-11-17 08:48:32

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited MedsFacts. If you have a question about OXYGEN SATURATION DECREASED and ATENOLOL, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited MedsFacts. If you have a noteworthy experience as a patient taking ATENOLOL, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults MedsFacts newest feature allows patients to consult - via realtime videoconferencing - experts in ATENOLOL. This premium feature connects patients to experts, regardless of geography. MedsFacts experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ATENOLOL experts. If you are a healthcare provider experienced in prescribing ATENOLOL, please register here.
© 2014 MedsFacts, Inc
Privacy Policy
Terms of Use